A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to evaluate the efficacy and safety of PDC-339 in the
treatment of acute erosive gastritis, using placebo as the comparator.
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
Department of Health, Executive Yuan, R.O.C. (Taiwan)